Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1999
12/09/1999WO1999062948A1 A human ubiquinone oxireductase subunit ci-b22 homolog gene (cbnafa09)
12/09/1999WO1999062947A1 A human ubiquinone oxireductase subunit ci-pdsw homolog gene (cblaic08)
12/09/1999WO1999062946A1 nrdF
12/09/1999WO1999062944A2 Protein oligomer compositions comprising endostatin protein and methods of using the same
12/09/1999WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/09/1999WO1999062941A2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
12/09/1999WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999WO1999062932A2 INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES
12/09/1999WO1999062927A1 Connective tissue growth factor-4
12/09/1999WO1999062926A1 Multiparametric fluorescence in situ hybridization
12/09/1999WO1999062925A1 Angiopoietin related gene sequence scarface 1
12/09/1999WO1999062923A2 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
12/09/1999WO1999062847A2 Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components
12/09/1999WO1999062592A1 Flow-through electroporation system for ex vivo gene therapy
12/09/1999WO1999062561A2 Gene therapy method
12/09/1999WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999WO1999062534A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
12/09/1999WO1999062527A1 nrdE
12/09/1999WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999WO1999062333A1 Bacteriophage-based transgenic fish for mutation detection
12/09/1999WO1999062332A1 TRANSGENIC ANIMALS LACKING A FUNCTIONAL GFRα2 RECEPTOR AS WELL AS METHODS FOR THEIR PRODUCTION AND USE
12/09/1999WO1999062316A2 Identification of lactic acid bacteria genes involved in the biosynthesis of exopolysaccharides
12/09/1999WO1999054487A3 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based dna library. application to the detection of mycobacteria
12/09/1999WO1999054445A3 Combination therapy using nucleic acids and conventional drugs
12/09/1999WO1999054444A3 Combination therapy using nucleic acids and radio therapy
12/09/1999WO1999054437A3 Novel molecules of the t125-related protein family and uses thereof
12/09/1999WO1999054435A3 Immortalised cell lines derived from normal human skin tissues
12/09/1999WO1999054340A8 Endotoxin reduction in nucleic acid purification
12/09/1999WO1999053067A3 Seed-coat promoters, genes and gene products
12/09/1999WO1999053037A3 Optimized nucleotide sequence encoding organophosphorous hydrolase and methods of use for same
12/09/1999WO1999052938A3 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
12/09/1999WO1999051777A3 Directed evolution biosensors
12/09/1999WO1999051754A9 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
12/09/1999WO1999051749A3 Recombinant potyvirus construct and use thereof
12/09/1999WO1999051266A3 Derivatives of pneumococcal choline binding proteins for vaccines
12/09/1999WO1999051264A3 Leishmania cysteine proteinases
12/09/1999WO1999050427A3 Novel basal endosperm transfer cell layer (betl) specific genes
12/09/1999WO1999050290A9 Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf)
12/09/1999WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999WO1999048917A3 Formulation having a papilloma virus-specific protein, and the production and use thereof
12/09/1999WO1999048486A3 Plant cell cyclin genes
12/09/1999WO1999047678A3 Interferon alpha plasmids and delivery systems, and methods of making and using the same
12/09/1999WO1999047657A3 Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles
12/09/1999WO1999045117A3 Interferon, ifn-hy and uses thereof
12/09/1999WO1999044943A3 Vectors and viruses used in gene therapy
12/09/1999WO1999041388A3 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
12/09/1999WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/09/1999WO1999036536A3 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
12/09/1999WO1999027081A3 Alpha/beta hydrolase-fold enzymes
12/09/1999WO1999024574A3 Plant homologs of yeast pad1, yeast crm1, and human jab1: regulators of ap-1 type transcription factor activity
12/09/1999WO1998051789A9 A METHOD TO CLONE mRNAs AND DISPLAY OF DIFFERENTIALLY EXPRESSED TRANSCRIPTS (DODET)
12/09/1999WO1998036053A3 Purified proteins, recombinant dna sequences and processes for producing caffeine free beverages
12/09/1999WO1998005673A8 Methods for purifying nucleic acids
12/09/1999DE19827957A1 Measuring electrical potential of single biological cell in nutrient, optionally carrying out micromanipulations
12/09/1999DE19825621A1 Protein zur Regulation von Apoptose Protein for regulation of apoptosis
12/09/1999DE19825494A1 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben The same new angiotensin receptor preparation and use
12/09/1999DE19825447A1 Neue Insulinanaloga mit erhöhter Zinkbildung New insulin analogues with increased zinc Education
12/09/1999DE19824900A1 DNA-Nachweis über einen Strangreassoziationskomplex DNA evidence of a Strangreassoziationskomplex
12/09/1999DE19824811A1 Verfahren zur Auslösung von Apoptose in Zellen Method for triggering of apoptosis in cells
12/09/1999CA2336612A1 Inhibition of viral infection and spread with viral and rhoa-derived peptides
12/09/1999CA2336295A1 Insulin-like growth factor binding protein-3 variants
12/09/1999CA2334171A1 Gene therapy method
12/09/1999CA2334117A1 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999CA2333394A1 Flow-through electroporation system for ex vivo gene therapy
12/09/1999CA2331370A1 Protein oligomer compositions comprising endostatin protein and methods of using the same
12/09/1999CA2331196A1 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/09/1999CA2331149A1 Phenotype modifying genetic sequences
12/09/1999CA2330833A1 Human minor vault protein p193
12/09/1999CA2330827A1 Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components
12/09/1999CA2330227A1 Method for triggering apoptosis in cells
12/09/1999CA2330225A1 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
12/09/1999CA2330191A1 Protease inhibitor peptides
12/09/1999CA2330187A1 Disulfide core polypeptides
12/09/1999CA2330180A1 Acyl coa:cholesterol acyltransferase related nucleic acid sequences
12/09/1999CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/09/1999CA2330171A1 Human protein c polypeptide
12/09/1999CA2330167A1 Genes of carotenoid biosynthesis and metabolism and methods of use thereof
12/09/1999CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999CA2329527A1 Endometriosis-associated gene
12/09/1999CA2329512A1 Il-6/sil-6r complex for promotion of liver functions
12/09/1999CA2329253A1 Multiparametric fluorescence in situ hybridization
12/09/1999CA2329247A1 Amino-modified ribozymes
12/09/1999CA2328895A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/09/1999CA2328891A1 G-protein coupled receptor, named 2871 receptor
12/09/1999CA2299611A1 Retinal calcium channel (alpha)1f-subunit gene
12/09/1999CA2299436A1 Use of prothymosin in the diagnosis and treatment of endometriosis
12/08/1999EP0962772A2 Improvements of biological assays for analyte detection
12/08/1999EP0962537A2 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
12/08/1999EP0962536A1 DNA detection by a strand reassociation complex
12/08/1999EP0962534A2 Expression vector containing regulatory sequences from an immunoglobulin locus
12/08/1999EP0962533A2 Sugar-responsive enhancers in alpha-amylase genes
12/08/1999EP0962532A1 Polypeptides and nucleic acids encoding the same for the diagnosis and prevention of tuberculosis disease.
12/08/1999EP0962531A2 Interferon-gamma production inducing isolated polypeptide fragment and an isolated DNA fragment encoding said polypeptide
12/08/1999EP0962530A2 Gene sequence encoding for the angiopoietin related protein scarface 1
12/08/1999EP0962529A1 Synthesis of human procollagens and collagens in recombinant DNA systems
12/08/1999EP0962528A2 Nucleic acids encoding acetylcholin-receptor subunits from insects
12/08/1999EP0962527A1 Molecule that homologizes genotype and phenotype and utilization thereof
12/08/1999EP0962526A2 Method for reversible modification of thermostable enzymes
12/08/1999EP0962525A1 Phage bonded to nuclear location signal
12/08/1999EP0962524A1 Apparatus and process for the intracellular manipulation of a biological cell
1 ... 3314 3315 3316 3317 3318 3319 3320 3321 3322 3323 3324 3325 3326 3327 3328 3329 3330 3331 3332 3333 3334 ... 4023